Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 3
2008 1
2009 4
2010 4
2011 5
2012 6
2013 5
2014 2
2015 4
2016 2
2017 2
2018 10
2019 2
2020 7
2021 9
2022 12
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Tests for tuberculosis infection: landscape analysis.
Hamada Y, Cirillo DM, Matteelli A, Penn-Nicholson A, Rangaka MX, Ruhwald M. Hamada Y, et al. Among authors: rangaka mx. Eur Respir J. 2021 Nov 25;58(5):2100167. doi: 10.1183/13993003.00167-2021. Print 2021 Nov. Eur Respir J. 2021. PMID: 33875495 Free article. Review.
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR Jr, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M. Getahun H, et al. Among authors: rangaka mx. Eur Respir J. 2015 Dec;46(6):1563-76. doi: 10.1183/13993003.01245-2015. Epub 2015 Sep 24. Eur Respir J. 2015. PMID: 26405286 Free PMC article. Review.
Reply to McShane.
Hill PC, Cobelens F, Martinez L, Garcia-Basteiro AL, Behr MA, Rangaka MX, Churchyard G, Evans T, Hanekom W, White RG. Hill PC, et al. Among authors: rangaka mx. J Infect Dis. 2024 Feb 14;229(2):616. doi: 10.1093/infdis/jiad466. J Infect Dis. 2024. PMID: 37897697 No abstract available.
Eliminating tuberculosis in low-burden countries.
Jackson C, Cohen T, Rangaka MX, Abubakar I. Jackson C, et al. Among authors: rangaka mx. Int J Tuberc Lung Dis. 2018 Jan 1;22(1):3. doi: 10.5588/ijtld.17.0707. Int J Tuberc Lung Dis. 2018. PMID: 29297418 No abstract available.
The impact of COVID-19 on global tuberculosis control.
Lipman M, McQuaid CF, Abubakar I, Khan M, Kranzer K, McHugh TD, Padmapriyadarsini C, Rangaka MX, Stoker N. Lipman M, et al. Among authors: rangaka mx. Indian J Med Res. 2021 Apr;153(4):404-408. doi: 10.4103/ijmr.IJMR_326_21. Indian J Med Res. 2021. PMID: 34380784 Free PMC article. No abstract available.
An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine Trials.
Hill PC, Cobelens F, Martinez L, Behr MA, Churchyard G, Evans T, Fiore-Gartland AJ, Garcia-Basteiro AL, Hanekom W, Rangaka MX, Vekemans J, White RG. Hill PC, et al. Among authors: rangaka mx. J Infect Dis. 2023 Nov 2;228(9):1150-1153. doi: 10.1093/infdis/jiad356. J Infect Dis. 2023. PMID: 37607272
Tracking COVID-19 using online search.
Lampos V, Majumder MS, Yom-Tov E, Edelstein M, Moura S, Hamada Y, Rangaka MX, McKendry RA, Cox IJ. Lampos V, et al. Among authors: rangaka mx. NPJ Digit Med. 2021 Feb 8;4(1):17. doi: 10.1038/s41746-021-00384-w. NPJ Digit Med. 2021. PMID: 33558607 Free PMC article.
World TB Day 2018: The Challenge of Drug Resistant Tuberculosis.
Gupta-Wright A, Tomlinson GS, Rangaka MX, Fletcher HA. Gupta-Wright A, et al. Among authors: rangaka mx. F1000Res. 2018 Feb 22;7:217. doi: 10.12688/f1000research.14088.1. eCollection 2018. F1000Res. 2018. PMID: 29527302 Free PMC article.
End-point definition and trial design to advance tuberculosis vaccine development.
Garcia-Basteiro AL, White RG, Tait D, Schmidt AC, Rangaka MX, Quaife M, Nemes E, Mogg R, Hill PC, Harris RC, Hanekom WA, Frick M, Fiore-Gartland A, Evans T, Dagnew AF, Churchyard G, Cobelens F, Behr MA, Hatherill M. Garcia-Basteiro AL, et al. Among authors: rangaka mx. Eur Respir Rev. 2022 Jun 7;31(164):220044. doi: 10.1183/16000617.0044-2022. Print 2022 Jun 30. Eur Respir Rev. 2022. PMID: 35675923 Free PMC article. Review.
85 results